Enteral Syringe Market Size, Share and Growth Outlook, 2026

Enteral Syringe Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Enteral Syringe Market size is forecast to increase from $1.85 Billion in 2026 to $2.8 Billion in 2034 at a CAGR of 5.3% between 2026 and 2034.

The Enteral Syringe market report provides detailed analysis and outlook of Enteral Syringe segments including By Product Type (Disposable Syringes, Reusable Syringes), By Capacity (Enteral, Catheter Tip, Large Volume ), By Tip (ENFit Connectors, Transition Sets), By Patient Group (Adult, Neonatal, Pediatric, Geriatric), By End User (Hospitals, Home Care Settings, Specialty Clinics, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Enteral Syringe Industry Overview

ISO 80369-3 Standardization Driving Global ENFit Syringe Transition

The enteral syringe industry is undergoing a major standardization shift driven by global adoption of ISO 80369-3 safety requirements, aimed at eliminating hazardous cross-connections between enteral and intravenous delivery systems. Avanos Medical issued a formal directive to global distributors confirming the discontinuation of its legacy NeoMed non-ENFit and orange-colored product lines. The commercial run-out is expected to conclude by early 2026, aligning the company’s entire enteral access portfolio with the ISO-compliant purple ENFit connector system. This transition is central to improving patient safety by enforcing standardized, non-compatible connectors across enteral feeding pathways. The global shift toward ENFit syringes is reshaping procurement strategies in hospitals, long-term care facilities, and homecare environments, reinforcing the role of regulatory-driven design standardization in enteral drug and nutrition delivery systems.

FDA-Cleared Enteral Syringe Innovations Enhancing Precision and Safety

Regulatory approvals are supporting the expansion of advanced enteral syringe designs that improve dosing accuracy and usability across clinical and homecare settings. The U.S. FDA granted marketing clearance to HaRi (Hardian Health) for its Profoject™ Enteral Feeding Syringe line under product classification code PNR. These clear, enteral-specific syringes are designed with dedicated safety connectors to ensure accurate measurement and controlled delivery of fluids, oral medications, and nutritional formulas. The product is intended for use in both institutional healthcare facilities and decentralized homecare environments. The introduction of FDA-cleared syringe systems reflects growing demand for standardized, precision-based dosing tools that minimize medication errors and enhance compatibility with ENFit-based enteral systems. The development of specialized syringe architectures is strengthening safety compliance across enteral feeding workflows.

OTC ENFit Syringes Expanding Home-Based Enteral Care Accessibility

The enteral syringe industry is increasingly shifting toward decentralized access models that support home-based enteral nutrition and medication administration. ENvue Medical launched over-the-counter (OTC) reusable ENFit syringes designed to improve accessibility for patients requiring ISO 80369-3 compliant enteral delivery systems. The product enables direct consumer access without prescription requirements, supporting broader use in homecare feeding pipelines. To enhance distribution efficiency, ENvue Medical partnered with U-Deliver as a strategic logistics provider in the United States, accelerating hospital, clinical, and retail pharmacy adoption of reusable ENFit syringes. This expansion reflects growing demand for patient-centric enteral care solutions that reduce institutional dependency while maintaining safety compliance. The increasing availability of reusable ENFit syringes is supporting long-term enteral therapy adherence in decentralized healthcare models.

Global Safety Compliance and Market Transition Frameworks Strengthening Syringe Standardization

Industry-wide regulatory coordination is accelerating the global transition toward standardized enteral syringe systems through structured compliance frameworks and clinical guidance. The Global Enteral Device Supplier Association (GEDSA) released its updated 2026 U.S. Conversion Rates framework and White Paper emphasizing the clinical importance of low-dose tip (LDT) and ENFit syringe access. The framework reinforces the elimination of legacy non-keyed oral adapters to fully implement ISO 80369-3 compliance and reduce medication misconnection risks. This transition is reshaping manufacturing priorities, procurement policies, and clinical training protocols across healthcare systems. The structured shift toward universal ENFit adoption is strengthening patient safety architecture in enteral feeding and medication administration environments.

Enteral Syringe Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Enteral Syringe market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Becton, Dickinson and Company (BD), Cardinal Health, Inc., B. Braun Melsungen AG, Avanos Medical, Inc., Fresenius Kabi AG, Vygon SAS, Medline Industries, LP, Baxter International Inc., ICU Medical, Inc., Amsino International, Inc.. The Enteral Syringe market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Enteral Syringe industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Enteral Syringe Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Enteral Syringe companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Enteral Syringe markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Enteral Syringe Market Competitive Benchmarking and Company Analysis

Leading companies in Enteral Syringe industry include- Becton, Dickinson and Company (BD), Cardinal Health, Inc., B. Braun Melsungen AG, Avanos Medical, Inc., Fresenius Kabi AG, Vygon SAS, Medline Industries, LP, Baxter International Inc., ICU Medical, Inc., Amsino International, Inc.. The Enteral Syringe market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Enteral Syringe Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Enteral Syringe market remains one of the strongest-performing segments in the country.
The US Enteral Syringe Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Enteral Syringe market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Enteral Syringe industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Enteral Syringe markets

Canada's strong Enteral Syringe sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Enteral Syringe market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Enteral Syringe Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Enteral Syringe market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Enteral Syringe population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Enteral Syringe industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Enteral Syringe market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Enteral Syringe sales through 2034

France Enteral Syringe companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Enteral Syringe Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Enteral Syringe distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Enteral Syringe Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Enteral Syringe market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Enteral Syringe industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Enteral Syringe industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Enteral Syringe Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Enteral Syringe market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Enteral Syringe market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Enteral Syringe Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Enteral Syringe Market Segmentation

By Product Type
Disposable Syringes
Reusable Syringes
By Capacity
Enteral
Catheter Tip
Large Volume
By Tip
ENFit Connectors
Transition Sets
By Patient Group
Adult
Neonatal
Pediatric
Geriatric
By End User
Hospitals
Home Care Settings
Specialty Clinics
Ambulatory Surgical Centers

Top Companies in Enteral Syringe Industry

Becton, Dickinson and Company (BD)
Cardinal Health, Inc.
B. Braun Melsungen AG
Avanos Medical, Inc.
Fresenius Kabi AG
Vygon SAS
Medline Industries, LP
Baxter International Inc.
ICU Medical, Inc.
Amsino International, Inc.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025